Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)

SHE:002727 Revenue

Yixintang Pharmaceutical Group had revenue of 4.03B CNY in the quarter ending June 30, 2026, a decrease of -2.76%. This brings the company's revenue in the last twelve months to 16.89B, down -4.09% year-over-year. In the year 2025, Yixintang Pharmaceutical Group had annual revenue of 17.34B, down -3.69%.

• Revenue (ttm): 16.89B
• Revenue Growth: -4.09%
• P/S Ratio: 0.40
• Revenue / Employee: 484.64K
• Employees: 34,848
• Market Cap: 6.80B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	17.34B	-664.21M	-3.69%
Dec 31, 2024	18.00B	620.14M	3.57%
Dec 31, 2023	17.38B	-51.30M	-0.29%
Jan 1, 2023	17.43B	2.84B	19.50%
Jan 1, 2022	14.59B	1.93B	15.26%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error